These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26303134)

  • 1. Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity.
    van Rhijn BD; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Am J Gastroenterol; 2015 Sep; 110(9):1289-97. PubMed ID: 26303134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal and Small Intestinal Mucosal Integrity in Eosinophilic Esophagitis and Response to an Elemental Diet.
    Warners MJ; Vlieg-Boerstra BJ; Verheij J; van Hamersveld PHP; van Rhijn BD; Van Ampting MTJ; Harthoorn LF; de Jonge WJ; Smout AJPM; Bredenoord AJ
    Am J Gastroenterol; 2017 Jul; 112(7):1061-1071. PubMed ID: 28417991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
    Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
    Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease activity in eosinophilic esophagitis is associated with impaired esophageal barrier integrity.
    Warners MJ; van Rhijn BD; Verheij J; Smout AJPM; Bredenoord AJ
    Am J Physiol Gastrointest Liver Physiol; 2017 Sep; 313(3):G230-G238. PubMed ID: 28546282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.
    Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T
    J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mucosal impedance measurements throughout the esophagus and mucosal eosinophil counts in endoscopic biopsy specimens in eosinophilic esophagitis.
    Alexander JA; Ravi K; Geno DM; Tholen CJ; Higginbotham TC; Wildhorn S; Camilleri M; Vaezi MF; Katzka DA
    Gastrointest Endosc; 2019 Apr; 89(4):693-700.e1. PubMed ID: 30145316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Esophageal Epithelial Integrity: More Complex than it Seems.
    Farré R
    Am J Gastroenterol; 2016 Feb; 111(2):295-6. PubMed ID: 26882948
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
    Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
    J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
    Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
    Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis.
    Weijenborg PW; Smout AJ; Verseijden C; van Veen HA; Verheij J; de Jonge WJ; Bredenoord AJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G323-9. PubMed ID: 24924748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
    Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
    Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis.
    Kruszewski PG; Russo JM; Franciosi JP; Varni JW; Platts-Mills TA; Erwin EA
    Dis Esophagus; 2016 May; 29(4):377-84. PubMed ID: 25721813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.
    Lucendo AJ; De Rezende LC; Jiménez-Contreras S; Yagüe-Compadre JL; González-Cervera J; Mota-Huertas T; Guagnozzi D; Angueira T; González-Castillo S; Arias A
    Dig Dis Sci; 2011 Dec; 56(12):3551-8. PubMed ID: 21674173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis.
    Kia L; Nelson M; Zalewski A; Gregory D; Gonsalves N; Straumann A; Hirano I
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 30380044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis.
    Katzka DA; Ravi K; Geno DM; Smyrk TC; Iyer PG; Alexander JA; Mabary JE; Camilleri M; Vaezi MF
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1242-1248.e1. PubMed ID: 25592662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Farré.
    van Rhijn BD; Bredenoord AJ
    Am J Gastroenterol; 2016 Feb; 111(2):296-7. PubMed ID: 26882949
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis.
    Katzka DA; Tadi R; Smyrk TC; Katarya E; Sharma A; Geno DM; Camilleri M; Iyer PG; Alexander JA; Buttar NS
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1824-9.e1. PubMed ID: 24681080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate.
    Remedios M; Campbell C; Jones DM; Kerlin P
    Gastrointest Endosc; 2006 Jan; 63(1):3-12. PubMed ID: 16377308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis.
    Abu-Sultaneh SM; Durst P; Maynard V; Elitsur Y
    Dig Dis Sci; 2011 Jan; 56(1):97-102. PubMed ID: 20458625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.